Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
Abstract Acute respiratory distress syndrome (ARDS) is a serious condition that can arise following direct or indirect acute lung injury (ALI). It is heterogeneous and has a high mortality rate. Supportive care is the mainstay of treatment and there is no definitive pharmacological treatment as yet....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-08-01
|
| Series: | Intensive Care Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44231-022-00012-5 |